Lyra Therapeutics Inc. (LYRA) NASDAQ
$6.22 (0.31) (-4.75%)
Market Cap: $390.12M
As of 03/28/24 04:00 PM EDT. Market closed.
Lyra Therapeutics Inc. (LYRA)
NASDAQ
$6.22
(0.31) (-4.75%)
Market Cap: $390.12M
As of 03/28/24 04:00 PM EDT. Market closed.
lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its ... read more
lyra therapeutics, inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. the company's xtreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. its product candidates include lyr-210 and lyr-220, which are bioresorbable polymeric matrices for the treatment of chronic rhinosinusitis. the company was formerly known as 480 biomedical, inc. and changed its name to lyra therapeutics, inc. in july 2018. lyra therapeutics, inc. was founded in 2005 and is headquartered in watertown, massachusetts. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Waksal Harlan | Executive Chair | Nov 10, 2023 | Buy | $2.96 | 25,000 | 74,095 | 261,966 | Nov 13, 2023, 05:29 PM |
NBVM GP, LLC | 10% Owner | May 31, 2023 | Buy | $2.43 | 1,805,416 | 4,387,161 | 2,521,745 | Jun 02, 2023, 04:15 PM |
ANDERSON EDWARD T | Director | May 31, 2023 | Buy | $2.43 | 1,805,416 | 4,387,161 | 2,521,745 | Jun 02, 2023, 04:11 PM |
PERCEPTIVE ADVISORS LLC | Director | May 31, 2023 | Buy | $2.49 | 3,610,832 | 8,999,999 | 11,469,117 | Jun 02, 2023, 04:11 PM |
MERRIFIELD C ANN | Director | Jun 10, 2022 | Buy | $5.05 | 4,000 | 20,200 | 11,328 | Jun 13, 2022, 04:05 PM |
MERRIFIELD C ANN | Director | May 16, 2022 | Buy | $5.00 | 328 | 1,640 | 7,328 | May 17, 2022, 05:35 PM |
MERRIFIELD C ANN | Director | May 13, 2022 | Buy | $4.81 | 3,500 | 16,846 | 7,000 | May 17, 2022, 05:35 PM |
PERCEPTIVE ADVISORS LLC | Director | Apr 12, 2022 | Buy | $4.22 | 5,924,170 | 24,999,996 | 7,858,285 | Apr 14, 2022, 04:53 PM |
NBVM GP, LLC | 10% Owner | Apr 12, 2022 | Buy | $4.22 | 2,369,667 | 9,999,994 | 1,855,443 | Apr 14, 2022, 04:14 PM |
ANDERSON EDWARD T | Director | Apr 12, 2022 | Buy | $4.22 | 118,483 | 499,998 | 118,483 | Apr 14, 2022, 04:08 PM |
ANDERSON EDWARD T | Director | Apr 12, 2022 | Buy | $4.22 | 2,369,667 | 9,999,994 | 1,855,443 | Apr 14, 2022, 04:08 PM |
Waksal Harlan | Executive Chair | Apr 12, 2022 | Buy | $4.22 | 236,966 | 999,996 | 236,966 | Apr 13, 2022, 07:16 PM |
snyderman nancy lynn MD | Director | Dec 16, 2020 | Buy | $9.72 | 1,025 | 9,963 | 1,025 | Dec 17, 2020, 04:05 PM |
PERCEPTIVE ADVISORS LLC | Director | May 05, 2020 | Buy | $16.00 | 625,000 | 10,000,000 | 1,934,115 | May 29, 2020, 05:34 PM |
Soleus Private Equity GP I, LLC | 10% Owner | May 05, 2020 | Buy | $16.00 | 155,000 | 2,480,000 | 155,000 | May 15, 2020, 06:16 PM |
Soleus Private Equity GP I, LLC | 10% Owner | May 05, 2020 | Sale | $16.00 | 16,909 | 270,544 | 457,421 | May 15, 2020, 06:16 PM |
Soleus Private Equity GP I, LLC | 10% Owner | May 05, 2020 | Option Exercise | $8.63 | 31,382 | 270,827 | 474,330 | May 15, 2020, 06:16 PM |
PERCEPTIVE ADVISORS LLC | Director | May 05, 2020 | Option Exercise | $16.00 | 259,346 | 4,149,536 | 1,309,115 | May 06, 2020, 09:10 PM |
PERCEPTIVE ADVISORS LLC | Director | May 05, 2020 | Option Exercise | $8.63 | 480,825 | 4,149,520 | 1,471,620 | May 06, 2020, 09:10 PM |
NBVM GP, LLC | 10% Owner | May 05, 2020 | Buy | $16.00 | 250,000 | 4,000,000 | 778,592 | May 06, 2020, 07:38 PM |
NBVM GP, LLC | 10% Owner | May 05, 2020 | Sale | $16.00 | 24,183 | 386,928 | 661,153 | May 06, 2020, 07:38 PM |
NBVM GP, LLC | 10% Owner | May 05, 2020 | Option Exercise | $8.63 | 44,831 | 386,892 | 672,513 | May 06, 2020, 07:38 PM |
ANDERSON EDWARD T | Director | May 05, 2020 | Buy | $16.00 | 250,000 | 4,000,000 | 778,592 | May 06, 2020, 07:32 PM |
ANDERSON EDWARD T | Director | May 05, 2020 | Sale | $16.00 | 24,183 | 386,928 | 661,153 | May 06, 2020, 07:32 PM |
ANDERSON EDWARD T | Director | May 05, 2020 | Option Exercise | $8.63 | 44,831 | 386,892 | 672,513 | May 06, 2020, 07:32 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | May 05, 2020 | Buy | $16.00 | 62,500 | 1,000,000 | 1,062,259 | May 06, 2020, 07:30 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | May 05, 2020 | Sale | $16.00 | 9,674 | 154,784 | 1,001,951 | May 06, 2020, 07:30 PM |
Polaris Venture Management Co. V, L.L.C. | 10% Owner | May 05, 2020 | Option Exercise | $8.63 | 17,932 | 154,753 | 1,011,285 | May 06, 2020, 07:30 PM |
WHITESIDES GEORGE M | Director | May 01, 2020 | Option Exercise | $16.00 | 19,661 | 314,576 | 48,660 | May 01, 2020, 06:35 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
GEODE CAPITAL MANAGEMENT, LLC | 336,458 | 0.00018% | 9% | Other |
BLACKROCK INC. | 110,797 | 0.00001% | 133.35% | Other |
RENAISSANCE TECHNOLOGIES LLC | 43,900 | 0.00036% | -11.85% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 28,795 | 0.00028% | New | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View